CLINICAL_TRIALS
trial_result
· 2019-08-01
Clinical Trial Update: Zurig (Febuxostat) 40mg Efficacy and Safety Trial [Phase 4]
Summary
Phase 4 trial updating the efficacy and safety of Zurig (Febuxostat) 40 mg for hyperuricemia has been completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Getz Pharma | Conditions: Hyperuricemia | Phase 4 | Status: COMPLETED